$1.09
+0.19 (+21.10%)
Analyst Consensus
Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,699.1% upside
Low Target
$14.26
Average Target
$19.61
High Target
$29.32
Current Price
$1.09
Current
$1.09
$1.09
Target
$19.61
$19.61
$14.26
$19.61 avg
$29.32
Scenario Analysis
Bear Case
$14.26
1,208.3%
Low target
Base Case
$19.61
+1,699.1%
Avg target
Bull Case
$29.32
+2,589.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.98
-63.4% from high
52-Week Low
$0.56
+93.5% from low
Target vs 52W High
$19.61
+558.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -0.5% |
| AMGN | Hold | 43 | 49% | $190.87 | -55.1% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +152.8% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -17.0% |
| REGN | Buy | 37 | 70% | $76.80 | -90.5% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -54.1% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -47.2% |
| BIIB | Buy | 43 | 67% | $91.45 | -57.0% |